王文鹏,黄光磊,薛英威.胃腺癌脉管浸润的临床病理特征及预后分析[J].肿瘤学杂志,2015,21(12):988-992.
胃腺癌脉管浸润的临床病理特征及预后分析
Analysis of Clinicopathological Features and Prognosis of Patients with Gastric Adenocarcinoma in Lymphatic Vessel and/or Venules Invasion
投稿时间:2015-08-21  
DOI:10.11735/j.issn.1671-170X.2015.12.B009
中文关键词:  胃腺癌  淋巴管  微静脉  淋巴结转移  预后
英文关键词:gastric adenocarcinoma  lymphaticvessel  venules  lymph node  metastasis  prognosis
基金项目:
作者单位
王文鹏 哈尔滨医科大学附属肿瘤医院 
黄光磊 哈尔滨医科大学附属肿瘤医院 
薛英威 哈尔滨医科大学附属肿瘤医院 
摘要点击次数: 1803
全文下载次数: 735
中文摘要:
      摘 要:[目的]探讨胃腺癌根治术后脉管浸润患者的临床病理特征及预后。[方法]回顾性分析行胃癌根治术的192例患者的临床病理资料,按脉管是否浸润分为两组:脉管浸润组[LV(+)组]47例和脉管未浸润组[LV(-)组]145例,分别比较其临床病理特征及预后差异。[结果]脉管浸润组和脉管未浸润组在年龄、肿瘤大小、大体类型、pT分期、pN分期、病理分期及手术方式方面差异均具有统计学意义(P<0.05),尤其与pN分期之间显著相关(P=0.007)。但在性别、肿瘤部位、组织分化程度上差异无统计学意义(P>0.05)。单因素生存分析显示,脉管浸润组3年生存率为27.7%,脉管未浸润组3年生存率56.6%,两者相比差异具有统计学意义(P<0.001)。进一步探讨脉管浸润与淋巴结转移的关系发现,脉管浸润伴随淋巴结转移者3年生存率21.4%,脉管未浸润伴随淋巴结转移者3年生存率45.1%,差异具有统计学意义(P<0.001)。多因素生存分析显示,脉管浸润(P=0.040,OR=1.595)、pT分期(P<0.001,OR=1.721)和pN分期(P=0.006,OR=1.354)是影响胃腺癌患者预后的独立因素。[结论]胃腺癌脉管浸润与淋巴结转移显著相关。脉管浸润的胃腺癌患者预后差,当脉管浸润伴随淋巴结转移时提示要比单纯的淋巴结转移预后更差。脉管浸润是影响胃腺癌患者预后的独立因素。
英文摘要:
      Abstract:[Purpose]To investigate the differences in clinicopathological features and prognosis of lymphatic vessel and/or venules invasion after radical gastrectomy.[Methods] Clinicopathological data of 192 patients with gastric adenocarcinoma undergone radical gastrectomy were analyzed retrospectively. These patients were divided into two groups whose differences were compared by clinicopathological features and prognosis:47 patients with lymphatic vessel and/or venules invasion[group LV(+)],145 patients without lymphatic vessel and/or venules invasion[group LV(-)].[Results] There were statistic differences between two groups in age,lesionsize,subtypes,pT classification,TNM stage,operation(P<0.05)and particularly in pN classification(P=0.007).Whereas,there was no statistic difference in gender,lesion location(P>0.05).Univariate survival analysis showed that the differences were statistically significant between the group invaded [group LV(+)] whose three year survival rate was 27.7% and the other group by no invasion [group LV(-)] whose three year survival rate was 56.6%(P<0.001).To further exoplore the relationship between lymphatic vessel and/or venules invasion(LV)and lymph node(LN),we found that there was statistically significance between lymphatic vessel and/or venules invasion associated with lymph node metastasis[group LV(+) LN(+)] whose three year survival rate was 45.1% and lymphatic vessel and/or venules invasion not associated with lymph node metastasis[group LV (-) LN(+)] whose three year survival rate was 21.4%(P<0.001).Multivariate survival analysis showed that lymphatic vessel and/or venules invasion(LV+)(P=0.040,OR=1.595),pT classification(P<0.01,OR=1.721)and pN(P=0.006,OR=1.354)classification were the independent prognostic factors of patients with gastric adenocarcinoma. [Conclusions] Lymphatic vessel and/or venules invasion of gastric adenocarcinoma is significantly associated with lymph node metastasis. The prognosis of lymphatic vessel and venules invasion is poor. Lymphatic vessel and/or venules invasion simultaneously accompanied by lymph node metastasis might prompt a worse prognosis than lymph node metastasis simply. Lymphatic vessel and/or venules invasion is an independent prognostic factor of patients with gastric adenocarcinoma.
在线阅读   查看全文  查看/发表评论  下载PDF阅读器